KURA ONCOLOGY, INC. Shareholders' Equity
KURA ONCOLOGY, INC. (KURA) had Shareholders' Equity of $48.43 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $48.43M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $107.88M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $174.13M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $242.54M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $48.43M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $107.88M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $174.13M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $242.54M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $305.49M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $364.41M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $413.64M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $423.77M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $466.07M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $505.08M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $397.27M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $429.94M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $459.68M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $395.18M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $420.28M 10-K · filed 2026-03-05 | |
| 2022-09-30 | $419.62M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $449.49M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $476.25M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $506.61M 10-K · filed 2025-02-28 | |
| 2021-09-30 | $533.76M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $558.55M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $585.99M 10-Q · filed 2022-08-03 | |
| 2020-12-31 | $610.90M 10-K · filed 2024-02-27 | |
| 2020-09-30 | $306.50M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $322.37M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $203.20M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $218.78M 10-K · filed 2023-02-23 | |
| 2019-09-30 | $233.58M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $246.58M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $149.56M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $160.99M 10-K · filed 2022-02-24 | |
| 2018-09-30 | $174.61M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $112.40M 10-Q · filed 2019-11-05 | |
| 2018-03-31 | $124.80M 10-Q · filed 2019-08-01 | |
| 2017-12-31 | $79.86M 10-K · filed 2021-02-24 | |
| 2017-09-30 | $89.20M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $43.64M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $50.24M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $56.88M 10-K · filed 2020-02-25 | |
| 2016-09-30 | $63.67M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $70.04M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $76.07M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $82.10M 10-K · filed 2018-03-12 | |
| 2015-09-30 | $37.78M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $43.32M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $48.89M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | -$3.43M 10-K · filed 2017-03-14 | -$154.69K 10-K · filed 2015-02-27 |
| 2014-09-30 | -$143.04K 10-Q · filed 2014-11-14 | |
| 2014-08-21 | $0.00 10-K · filed 2016-03-17 | |
| 2014-06-30 | -$136.61K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$129.72K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$123.96K 10-K · filed 2015-02-27 | |
| 2013-09-30 | -$114.21K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$108.07K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$101.32K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$95.35K 10-K · filed 2015-02-27 | |
| 2012-09-30 | -$85.68K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$79.67K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$73.40K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$68.03K 10-K · filed 2015-02-27 | |
| 2011-09-30 | -$59.15K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$52.88K 10-Q · filed 2011-08-15 | |
| 2011-03-31 | -$68.03K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | -$40.99K 10-K · filed 2015-02-27 | |
| 2009-12-31 | -$18.60K 10-K · filed 2015-02-27 | |
| 2008-12-31 | $1.40K 10-K · filed 2015-02-27 | |
| 2007-12-31 | $35.02K 10-K · filed 2015-02-27 | |
| 2007-11-16 | $0.00 10-K · filed 2012-03-30 | |
| 2007-11-14 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |